An article by the Center for Science in the Public Interest classified all available published placebo-controlled trials of SSRI’s in children and adolescents as industry-funded or non-industry funded. The results showed that 90% of industry-funded trials in the published literature were reported as positive, while only 55.6% of non-industry-funded trials were positive.